Kanagawa, Japan

Takeo Sekiya

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Sekiya. Retrieved from https://idiyas.com/inventor/takeo-sekiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takeo Sekiya: Innovator in Transgenic Research

Introduction

Takeo Sekiya is a prominent inventor based in Kanagawa, Japan. He is known for his significant contributions to the field of genetic research, particularly in the development of transgenic models for cancer research. His work has implications for understanding carcinogenesis and developing preventive strategies against tumors.

Latest Patents

Takeo Sekiya holds a patent for a transgenic rat that incorporates the human normal type c-Ha-ras gene. This invention provides a valuable tool for screening various carcinogens and identifying promoters of carcinogenesis. It also facilitates the analysis of the mechanisms underlying tumor development, thereby advancing cancer research.

Career Highlights

Throughout his career, Takeo Sekiya has focused on innovative approaches to studying cancer. His work has contributed to a deeper understanding of genetic factors involved in tumor formation. He has been recognized for his research and its potential impact on medical science.

Collaborations

Takeo Sekiya has collaborated with notable researchers in his field, including Hiroyasu Toriyama and Takahiro Ochiya. These collaborations have enhanced the scope and depth of his research, leading to advancements in transgenic technology.

Conclusion

Takeo Sekiya's contributions to transgenic research exemplify the importance of innovation in understanding cancer mechanisms. His work continues to influence the field and offers hope for future advancements in cancer prevention and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…